Forget buy-to-let! I’d buy these 2 FTSE 100 stocks to retire early

I think these two FTSE 100 (INDEXFTSE:UKX) shares could offer improving growth outlooks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The outlook for the buy-to-let industry may be more positive following the general election. Fears surrounding a Jeremy Corbyn-led government and potential changes to taxation may mean that house prices make gains in the short run.

However, in the long run, the FTSE 100 could outperform buy-to-let investments. It appears to offer superior value for money, greater diversity and a range of stocks with sound growth strategies.

With that in mind, here are two FTSE 100 shares that could deliver impressive long-term total returns. They could help to bring your retirement date a step closer.

AstraZeneca

Recent updates from pharma stock AstraZeneca (LSE: AZN) have provided evidence of the scale of its turnaround. While in previous years it has struggled to generate top- and bottom-line growth, its sales and profitability are now growing at double-digit rates. This trend could continue over the medium term as the business benefits from the major investment it has made in its pipeline over recent years.

Risks facing UK investors may have subsided following the recent general election. However, global growth uncertainties remain in place. For example, political risk in the US and China may continue to be high in 2020, while tariffs could act as a drag on global GDP growth. Therefore, AstraZeneca’s defensive characteristics could help it to outperform many of its FTSE 100 peers. Its reduced dependency on the wider economy’s performance may mean that it becomes more popular among investors.

As such, now could be the right time to buy a slice of the company. Its improving financial performance and increasing favour among investors may mean that it outpaces house price growth in the long run.

Bunzl

One FTSE 100 share that is being negatively impacted by an uncertain global macroeconomic outlook is Bunzl (LSE: BNZL). The international distribution and services company recently released a trading update that showed the slowing sales trend from earlier in 2019 has continued.

For example, in its third quarter, the company reported a rise in sales at constant exchange rates of just 0.5%. When the impact of acquisitions is excluded, its sales declined by 1%.

Looking ahead, Bunzl has an active acquisition pipeline. It has already spent £100m on acquisitions this year, and is likely to continue to add new businesses to its portfolio over the medium term. They could catalyse its financial performance and help to offset an uncertain trading period for the business.

With a solid track record of growth that includes five continuous years of increasing earnings, Bunzl could offer long-term growth potential. Following its 12% share price decline in the last year, now could be the right time to buy a slice of it while it trades on a lower valuation. It may fail to recover significantly in the short run, but could offer turnaround potential in the coming years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

5 UK shares I’d put my whole year’s ISA in for passive income

Christopher Ruane chooses a handful of UK shares he would buy in a £20K ISA that ought to earn him…

Read more »

Investing Articles

£8,000 in savings? Here’s how I’d use it to target a £5,980 annual passive income

Our writer explains how he would use £8,000 to buy dividend shares and aim to build a sizeable passive income…

Read more »

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

£10,000 in savings? That could turn into a second income worth £38,793

This Fool looks at how a lump sum of savings could potentially turn into a handsome second income by investing…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

I reckon this is one of Warren Buffett’s best buys ever

Legendary investor Warren Buffett has made some exceptional investments over the years. This Fool thinks this one could be up…

Read more »

Investing Articles

Why has the Rolls-Royce share price stalled around £4?

Christopher Ruane looks at the recent track record of the Rolls-Royce share price, where it is now, and explains whether…

Read more »

Investing Articles

Revealed! The best-performing FTSE 250 shares of 2024

A strong performance from the FTSE 100 masks the fact that six FTSE 250 stocks are up more than 39%…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

This FTSE 100 stock is up 30% since January… and it still looks like a bargain

When a stock's up 30%, the time to buy has often passed. But here’s a FTSE 100 stock for which…

Read more »

Young black man looking at phone while on the London Overground
Investing Articles

This major FTSE 100 stock just flashed a big red flag

Jon Smith flags up the surprise departure of the CEO of a major FTSE 100 banking stock as a reason…

Read more »